SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
Clinical trials for SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New cancer drug trial seeks to tame advanced tumors
Disease control Recruiting nowThis early-stage study is testing a new immunotherapy drug called JANX008 in adults with advanced or spreading solid tumors that have stopped responding to standard treatments. The main goals are to find a safe dose and see if the drug shows any signs of fighting the cancer. Abou…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
Phase: PHASE1 • Sponsor: Janux Therapeutics • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New Two-Drug attack tested to shrink tumors before cancer surgery
Disease control Recruiting nowThis study is testing whether giving two drugs—ficerafusp alfa (an experimental drug) and pembrolizumab (an approved immunotherapy)—before surgery can help shrink tumors and improve outcomes for people with high-risk, operable head and neck cancer. The goal is to see if this pre-…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New vaccine could spare throat cancer patients from radiation
Disease control Recruiting nowThis study is testing if adding an experimental vaccine (PRGN-2009) to standard chemotherapy can effectively treat newly diagnosed HPV-linked throat cancer. The goal is to see if this combination can control the cancer so well that patients can avoid radiation therapy, which ofte…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New cancer drug enters first human trials for multiple advanced cancers
Disease control Recruiting nowThis is a first-in-human study to test the safety and find the right dose of a new drug called PF-08046054/SGN-PDL1V for people with advanced solid tumors. It will be tested alone and in combination with another cancer drug, pembrolizumab. The study is recruiting 714 participants…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
Phase: PHASE1 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
New cancer vaccine trial aims to train immune system to fight tumors
Disease control Recruiting nowThis early-stage study is testing a new cancer vaccine called Modi-1. The goal is to see if it is safe and can help the body's immune system fight advanced forms of breast, head and neck, ovarian, and kidney cancer. Researchers will give the vaccine alone or combined with other a…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
Phase: PHASE1, PHASE2 • Sponsor: Scancell Ltd • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
Experimental cancer injection trial seeks to shrink tumors
Disease control Recruiting nowThis early-stage study is testing whether directly injecting an experimental treatment called VLPONC-01 into head and neck tumors is safe and can help shrink them. Researchers are enrolling 41 patients with advanced or surgically removable cancers to receive the injections, somet…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
Phase: PHASE1 • Sponsor: VLP Therapeutics • Aim: Disease control
Last updated Mar 04, 2026 15:29 UTC